Some reports showed that Sox2 expression was associated with poorer overall survival in gastric cancer[11–12]; however, others argued that the expression of Sox2 decreased during gastric carcinogenesis and this was predictive of better survival[13]. The gene discussed is SOX2; the disease is gastric cancer.